Moreover, ERS can promote the activation of Nrf2, JNK, NF-κβ and CHOP, and actively takes part in inflammation and OS, thus inducing the progression of NAFLD (Lebeaupin et al., 2018; Zhang et al., 2014). Here, NFKB1 is linked to metabolic dysfunction-associated steatotic liver disease.